Drug Repositioning: Bringing New Life to Shelved Assets and Existing Drugs

Michael J. Barratt; Donald E. Frail

doi:10.1002/9781118274408

Drug Repositioning: Bringing New Life to Shelved Assets and Existing Drugs

Michael J. Barratt, Donald E. Frail

Division of Laboratory and Genomic Medicine

Research output: Book/Report › Book › peer-review

67 Scopus citations

Abstract

Drug repositioning, also known as drug reprofiling or repurposing, has become an increasingly important part of the drug development process. This book examines the business, technical, scientific, and operational challenges and opportunities that drug repositioning offers. Readers will learn how to perform the latest experimental and computational methods that support drug repositioning, and detailed case studies throughout the book demonstrate how these methods fit within the context of a comprehensive drug repositioning strategy.

Original language	English
Publisher	John Wiley and Sons
ISBN (Print)	9780470878279
DOIs	https://doi.org/10.1002/9781118274408
State	Published - Apr 8 2012

Access to Document

10.1002/9781118274408

Cite this

@book{3a0448b094d44a9388f4adb034254b2e,

title = "Drug Repositioning: Bringing New Life to Shelved Assets and Existing Drugs",

abstract = "Drug repositioning, also known as drug reprofiling or repurposing, has become an increasingly important part of the drug development process. This book examines the business, technical, scientific, and operational challenges and opportunities that drug repositioning offers. Readers will learn how to perform the latest experimental and computational methods that support drug repositioning, and detailed case studies throughout the book demonstrate how these methods fit within the context of a comprehensive drug repositioning strategy.",

author = "Barratt, {Michael J.} and Frail, {Donald E.}",

year = "2012",

month = apr,

day = "8",

doi = "10.1002/9781118274408",

language = "English",

isbn = "9780470878279",

publisher = "John Wiley and Sons",

}

TY - BOOK

T1 - Drug Repositioning

T2 - Bringing New Life to Shelved Assets and Existing Drugs

AU - Barratt, Michael J.

AU - Frail, Donald E.

PY - 2012/4/8

Y1 - 2012/4/8

N2 - Drug repositioning, also known as drug reprofiling or repurposing, has become an increasingly important part of the drug development process. This book examines the business, technical, scientific, and operational challenges and opportunities that drug repositioning offers. Readers will learn how to perform the latest experimental and computational methods that support drug repositioning, and detailed case studies throughout the book demonstrate how these methods fit within the context of a comprehensive drug repositioning strategy.

AB - Drug repositioning, also known as drug reprofiling or repurposing, has become an increasingly important part of the drug development process. This book examines the business, technical, scientific, and operational challenges and opportunities that drug repositioning offers. Readers will learn how to perform the latest experimental and computational methods that support drug repositioning, and detailed case studies throughout the book demonstrate how these methods fit within the context of a comprehensive drug repositioning strategy.

UR - http://www.scopus.com/inward/record.url?scp=84891562716&partnerID=8YFLogxK

U2 - 10.1002/9781118274408

DO - 10.1002/9781118274408

M3 - Book

AN - SCOPUS:84891562716

SN - 9780470878279

BT - Drug Repositioning

PB - John Wiley and Sons

ER -

Drug Repositioning: Bringing New Life to Shelved Assets and Existing Drugs

Abstract

Access to Document

Other files and links

Fingerprint

Cite this